Labcorp announced an agreement to acquire select assets of BioReference Health from OPKO Health for $722 million in cash, with potential additional earnouts. This acquisition includes clinical and women's health testing services, urology, corrections, over 80 patient service centers, and the proprietary FDA-approved 4Kscore Test for prostate cancer risk assessment. The deal aims to broaden Labcorp's specialty testing menu and improve access to high-quality lab services across the U.S. The transaction is subject to regulatory approval and is expected to enhance patient care by providing more diagnostic options and data tools nationwide.
Labcorp's acquisition deal with OPKO Health provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 15, 2026 18:13 WIB: Among 150 priced US health stocks, 93 rose and 49 fell. Notable movers include AXGN at USD 33.97 with a 3.33% drop and 61% buy order activity, FLNA at USD 0.71 down 3.23% with balanced buy/sell orders, and NVAX at USD 12.24 down 3.16% with 72% sell orders. Typical hold times range from 18 to 59 days.
The Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $52.5 million in 2025 to $162.16 million by 2034, at a CAGR of 13.35%. Growth is fueled by rising maternal age, advances in molecular diagnostics, and increased he...
TiDB, powered by PingCAP, announced new cloud platform capabilities to support enterprise and AI applications on a unified data foundation. Key updates include the upcoming general availability of TiDB Cloud Premium, public previews of Bring Your Own...
Alcoa will release its Q3 2026 earnings on October 15, with analysts divided on earnings per share and revenue forecasts due to factors like rising aluminum sales, inventory changes, and higher input costs. The company expects a 54.9% jump in aluminu...
Nokia has transferred 2,142,361 of its own shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was made without compensation and is part of fulfilling commitments u...
Pallavi Mahajan, a senior manager at Nokia Corporation, received 35,192 shares through a share-based incentive on October 15, 2026. This transaction was reported under EU Market Abuse Regulation, reflecting Nokia's ongoing use of equity incentives to...
